Could PDUFA VIII Align With Trump’s Efficiency Emphasis?

 
• By Sue Sutter

Given the Trump Administration’s intense focus on cutting costs and increasing efficiency, industry and the FDA should focus on what is and is not working in PDUFA VII when negotiating the next agreement, lobbyists said at the BIO CEO and Investor Conference.

Car lights at night
PDUFA VIII negotiations offer a chance to align the FDA's user fee program with the Trump Administration's focus on efficiency, lobbyists said. (Shutterstock)

More from User Fees

More from Conferences